CLINICAL TRIALS

Multiple Sclerosis

Active clinical trials and verified researcher listings for Multiple Sclerosis, simplified into plain English.

ABOUT MULTIPLE SCLEROSIS

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks myelin, the insulating cover of nerve cells in the human body, causing damage to one's own central nervous system. It is a type of demyelinating disease, where the nervous system's ability to transmit signals is damaged. Symptoms can be physical, mental, or both, including double vision, vision loss, eye pain, muscle weakness, loss of sensation and coordination.

Patient info on MedlinePlus →Wikipedia ↗

Source: Wikipedia. For educational use only — not medical advice.

ACTIVELY RECRUITING TRIALS

COMMON QUESTIONS

Are there clinical trials currently recruiting for Multiple Sclerosis?

Yes. This page displays actively recruiting Multiple Sclerosis clinical trials sourced in real time from ClinicalTrials.gov. Use the filters to narrow by phase, status, and location.

How do I join a clinical trial for Multiple Sclerosis?

Browse the trials listed above, review the eligibility criteria for each study, and submit a contact request directly to the research team. You can also speak to your physician about a referral.

Are Multiple Sclerosis clinical trials free to participate in?

Most clinical trials cover the cost of the investigational treatment and all study-related visits. Some studies also offer compensation for time and travel. Always confirm costs and insurance coverage with the trial coordinator before enrolling.

What eligibility requirements apply to Multiple Sclerosis trials?

Requirements vary by study. Common criteria include a confirmed Multiple Sclerosis diagnosis, age range, prior treatments, and general health status. Each trial listing shows its specific inclusion and exclusion criteria.

What phases of Multiple Sclerosis trials are available?

Multiple Sclerosis trials span Phase I (safety testing), Phase II (effectiveness), Phase III (comparison to standard care), and Phase IV (post-approval monitoring). Phase II and III trials are most commonly open to new participants.

RELATED CONDITIONS

ALS / Lou Gehrig's DiseaseAlzheimer's DiseaseEpilepsy / SeizuresParkinson's Disease